other material
confidence high
sentiment positive
materiality 0.60
Aethlon Medical receives second ethics approval for Hemopurifier cancer trial in Australia
AETHLON MEDICAL INC
- Bellberry Human Research Ethics Committee granted full ethics approval to Pindara Private Hospital for Hemopurifier trial in solid tumors not responding to anti-PD-1 antibodies.
- This is the second ethics committee approval; the first came from Royal Adelaide Hospital in June 2024.
- The trial will be conducted by Dr. Marco Matos at Pindara Private Hospital in Queensland, Australia.
- Next steps include Research Governance Office approval, then Site Initiation Visits before patient enrollment can begin.
- Primary endpoint is safety; the trial plans to enroll 9–18 patients and will explore extracellular vesicle reduction.